2-bromo-4,4,4-trifluorobutanal | 1152617-07-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-bromo-4,4,4-trifluorobutanal
• 英文别名: 2-Bromo-4,4,4-trifluorobutyraldehyde
• CAS: 1152617-07-6
• 化学式: C₄H₄BrF₃O
• 分子量: 204.974
• InChiKey: LVMYYPJHCRTDJI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-氯-3-碘吡啶-2-胺 、 2-bromo-4,4,4-trifluorobutanal 在 MeOH water TFA 、 3u 、 乙醇 、 crude mixture 、 乙酸乙酯 、 Brine 、 magnesium sulfate 、 13 、 hexanes 作用下， 以 乙醇 为溶剂， 反应 2.0h， 以Collected fractions to give 7-chloro-8-iodo-3-(2,2,2-trifluoroethyl)imidazo[1,2-a]pyridine (261 mg, 73.7% yield) as a sticky yellow oil的产率得到7-chloro-8-iodo-3-(2,2,2-trifluoroethyl)imidazo[1,2-a]pyridine
  参考文献：
  名称：

  Positive allosteric modulators of mGluR2

  摘要：

  该披露通常涉及公式I的化合物，包括它们的盐，以及使用这些化合物的组合物和方法。这些化合物调节mGluR2受体，可能有助于治疗各种中枢神经系统的疾病。

  公开号：

  US08765767B2
• 作为产物：
  描述：

  4,4,4-三氟丁醛 在 溴 作用下， 以 乙醚 为溶剂， 反应 4.0h， 以91%的产率得到2-bromo-4,4,4-trifluorobutanal
  参考文献：
  名称：

  Positive Allosteric Modulators of MGLUR2

  摘要：

  该披露通常涉及到公式I的化合物，包括它们的盐，以及使用这些化合物的组合物和方法。这些化合物调节mGluR2受体，可能有助于治疗中枢神经系统的各种疾病。

  公开号：

  US20130245042A1

文献信息

• Positive Allosteric Modulators of MGLUR2
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US20130245042A1

  公开（公告）日：2013-09-19

  The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds modulate the mGluR2 receptor and may be useful for the treatment of various disorders of the central nervous system.

  该披露通常涉及到公式I的化合物，包括它们的盐，以及使用这些化合物的组合物和方法。这些化合物调节mGluR2受体，可能有助于治疗中枢神经系统的各种疾病。
• [EN] INDOLE AND BENZOXAZINE DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS<br/>[FR] DÉRIVÉS D'INDOLE ET DE BENZOXAZINE COMME MODULATEURS DES RÉCEPTEURS MÉTABOTROPIQUES AU GLUTAMATE
  申请人：ORTHO MCNEIL JANSSEN PHARM

  公开号：WO2010060589A1

  公开（公告）日：2010-06-03

  The present invention relates to novel indole and benzoxazine derivatives which are positive allosteric modulators of the metabotropic glutamate receptor subtype 2 ("mGluR2") and which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, and to the use of such compounds for the prevention or treatment of neurological and psychiatric disorders and diseases in which mGluR2 is involved.

  本发明涉及新型吲哚和苯并噁嗪衍生物，它们是代谢型谷氨酸受体亚型2（"mGluR2"）的正向变构调节剂，用于治疗或预防与谷氨酸功能障碍相关的神经和精神疾病，以及涉及代谢型受体亚型mGluR2的疾病。该发明还涉及包含这些化合物的药物组合物，用于制备这些化合物和组合物的过程，以及利用这些化合物预防或治疗涉及mGluR2的神经和精神疾病和疾病。
• INDOLE AND BENZOXAZINE DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS
  申请人：Cid-Nunez Jose Maria

  公开号：US20120035167A1

  公开（公告）日：2012-02-09

  The present invention relates to novel indole and benzoxazine derivatives which are positive allosteric modulators of the metabotropic glutamate receptor subtype 2 (“mGluR2”) and which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, and to the use of such compounds for the prevention or treatment of neurological and psychiatric disorders and diseases in which mGluR2 is involved.

  本发明涉及新型吲哚和苯并噁嗪衍生物，其为代谢型谷氨酸受体亚型2（“mGluR2”）的正向变构调节剂，并且对于治疗或预防与谷氨酸功能障碍相关的神经和精神障碍以及涉及代谢型受体亚型mGluR2的疾病具有用途。本发明还涉及包含这些化合物的制药组合物，制备这些化合物和组合物的过程以及使用这些化合物预防或治疗涉及mGluR2的神经和精神障碍和疾病。
• Positive allosteric modulators of mGluR2
  申请人：Bristol-Myers Squibb Company

  公开号：US08765767B2

  公开（公告）日：2014-07-01

  The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds modulate the mGluR2 receptor and may be useful for the treatment of various disorders of the central nervous system.

  该披露通常涉及公式I的化合物，包括它们的盐，以及使用这些化合物的组合物和方法。这些化合物调节mGluR2受体，可能有助于治疗各种中枢神经系统的疾病。
• Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
  申请人：Trabanco-Suarez Andres Avelino

  公开号：US08785486B2

  公开（公告）日：2014-07-22

  The present invention relates to novel compounds, in particular novel imidazo[1,2-a]piridine derivatives according to Formula (I). The compounds according to the invention are positive allosteric modulators of metabotropic receptors-sub-type 2 (‘mGluR2’) which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. In particular, such diseases are central nervous system disorders selected from the group of anxiety, schizophrenia, migraine, depression, and epilepsy. The invention is also directed to pharmaceutical compositions and processes to prepare such compounds and compositions, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR2 is involved.

  本发明涉及新型化合物，特别是公式（I）中的新型咪唑[1,2-a]吡啶衍生物。本发明的化合物是代谢型受体亚型2（“mGluR2”）的正向变构调节剂，可用于治疗或预防与谷氨酸功能障碍有关的神经和精神障碍以及涉及代谢型受体亚型2的疾病。特别是，这些疾病是来自焦虑、精神分裂症、偏头痛、抑郁症和癫痫等中枢神经系统疾病的选择性。本发明还涉及制备这种化合物和组合物的制药组合物和过程，以及使用这种化合物预防和治疗涉及mGluR2的这些疾病。